Methotrexate: still the anchor drug in RA treatment

Joint Bone Spine. 2009 Oct;76(5):452-4. doi: 10.1016/j.jbspin.2009.05.007. Epub 2009 Jun 27.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Monitoring / methods
  • Drug Monitoring / standards
  • Evidence-Based Medicine
  • Fatigue / chemically induced
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Netherlands
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Methotrexate